BriaCell Therapeutics

1D
1W
1M
3M
1Y
5Y

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell BCTX and other ETFs, options, and stocks.

About BCTX

BriaCell Therapeutics Corp. operates as a clinical-stage biotechnology company that specializes in immunotherapy for advanced breast cancer. It is advancing its targeted immunotherapy program by conducting a Phase I/IIA clinical trial with Bria-IMT in combination with an immune checkpoint inhibitor and a companion diagnostic test, BriaDx, to identify patients to benefit from Bria-IMT. 

CEO
William V. Williams
CEOWilliam V. Williams
Employees
6
Employees6
Headquarters
West Vancouver, British Columbia
HeadquartersWest Vancouver, British Columbia
Founded
2006
Founded2006
Employees
6
Employees6

BCTX Key Statistics

Market cap
91.49M
Market cap91.49M
Price-Earnings ratio
Price-Earnings ratio
Dividend yield
Dividend yield
Average volume
732.81K
Average volume732.81K
High today
$5.90
High today$5.90
Low today
$5.58
Low today$5.58
Open price
$5.80
Open price$5.80
Volume
151.53K
Volume151.53K
52 Week high
$12.47
52 Week high$12.47
52 Week low
$4.06
52 Week low$4.06

BCTX Earnings

-$0.52
-$0.35
-$0.17
$0.00
Q2 FY21
Q3 FY21
Q4 FY21
Q1 FY22
Q2 FY22
Q3 FY22
Q4 FY22
Estimated
per share
Estimated per share
Actual
Expected Oct 31, Pre-Market
ActualExpected Oct 31, Pre-Market
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, a registered broker-dealer and Member SIPC.